![](/images/graphics-bg.png)
Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
Joint Authors
Johnson, Matthew E.
Buyyounouski, Mark K.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-12-30
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Androgen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer.
Androgen deprivation has been associated with a wide range of iatrogenic effects impacting a variety of body systems including metabolic, musculoskeletal, cardiovascular, neurocognitive, and sexual.
This review aims to provide the radiation oncology community with the knowledge to monitor and manage androgen deprivation therapy toxicity in an effort to provide the highest level of care for patients and to minimize the iatrogenic effects of androgen deprivation as much as possible.
American Psychological Association (APA)
Johnson, Matthew E.& Buyyounouski, Mark K.. 2012. Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy. Prostate Cancer،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-482381
Modern Language Association (MLA)
Johnson, Matthew E.& Buyyounouski, Mark K.. Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy. Prostate Cancer No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-482381
American Medical Association (AMA)
Johnson, Matthew E.& Buyyounouski, Mark K.. Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy. Prostate Cancer. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-482381
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-482381